Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.765 USD | +0.79% | +3.22% | -34.88% |
02:15pm | Earnings Flash (PRME) PRIME MEDICINE Reports Q1 Revenue $591,000 | MT |
04-29 | Prime Medicine Shares Jump After Application for Chronic Granulomatous Disease Treatment Gets FDA Clearance | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.88% | 659M | |
+3.27% | 108B | |
+10.97% | 104B | |
+1.28% | 22.33B | |
-11.98% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.13% | 17.64B | |
+5.07% | 14.05B | |
+34.50% | 12.51B |
- Stock Market
- Equities
- PRME Stock
- News Prime Medicine, Inc.
- Prime Medicine Names Foghorn Therapeutics' CFO to be its New Finance Chief